EN PL

EMA: Draft guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells

29.06.2010
This guideline defines scientific principles and provides guidance for the development and evaluation of medicinal products containing genetically modified cells intended for use in humans. Its focus is on the quality, safety and efficacy requirements of genetically modified cells developed as medicinal products.